4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-109940
Chief Medical Officer gave up 1,395 shares (to pay taxes)
- Chief Medical Officer acquired 2,813 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-10-16 | Option exercise | +2,813 | 33,766 | D: show line 1 in the form | ||
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-10-16 | Shares withheld for taxes | −1,395 | $3.57 | $4,980 | 32,371 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2023-10-16 | Option exercise · Restricted Stock Units | −2,813 | 14,064 | D: show line 3 in the form |
Loading xslF345X05/tm2328751-1_4seq1.xml…